Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
Trial ID or NCT#
NCT06850623
Status
RECRUITING
Purpose
The purpose of the study is to assess the efficacy and safety of Acoustic Cluster Therapy (ACT) when given in addition to chemotherapy for treatment of Locally Advanced Pancreatic Cancer.
Official Title
A Phase 2 Study to Investigate the Efficacy and Safety of Acoustic Cluster Therapy With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer
Investigator(s)
Pejman Ghanouni, MD, PhD
Radiologist
Professor of Radiology (Body MRI) and, by courtesy, of Neurosurgery, of Obstetrics and Gynecology and of Urology
George A Fisher
Medical oncologist,
Gastrointestinal specialist
Colleen Haas Chair in the School of Medicine, Emeritus
Gregory Marshal Heestand
Medical oncologist,
Gastrointestinal specialist
Clinical Associate Professor, Medicine - Oncology
Contact us to find out if this trial is right for you.
Contact
Britney Williams
650-736-3688
View on ClinicalTrials.gov
